STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 10




                                 into their precursor cells in vivo or in vitro. However, materials and methods                                        
                                 of the invention can reprogram differentiated cells into immortalized,                                                
                                 totipotent cells. Differentiated cells can be isolated from a fetus or a live bom                                     
                                 animal, for example.                                                                                                  
                         Strelchenko Application 09/357,445, Paper I (specification), p. 17,11. 17-23.                                                 
                F 54- According to Strelchenko's written description, the conversion of non-totipotent cells to                                        
                         totipotent cells prior to their use as donor cells is an important aspect of Strelchenko's                                    
                         process and allows virtually any cell to be used as a donor cell. Strelchenko Application                                     
                         09/357,445, Paper I (specification), p. 12,11. 3-11 and p. 17,1. 28 - p. 18,1. 2.                                             
                F 55. According to Strelchenko a non-totipotent cell may be converted to a totipotent cell using                                       
                         "features of the invention:"                                                                                                  
                                 a non-totipotent precursor cell can be converted into a totipotent cell by                                            
                                 utilizing features of the invention described hereafter.                                                              
                         Strelchenko Application 09/357,445, Paper I (specification), p. 12,11. 11-12.                                                 
                F 56. Strelchenko calls this conversion of non-totipotent to totipotent cells "reprogramming:"                                         
                                 This conversion process can be referred to as a reprogramming step.                                                   
                         Strelchenko Application 09/357,445, Paper I (specification), p. 12,1. 13.                                                     
                F 57. Strelchenko's specification further describes reprogramming:                                                                     
                                 The term "reprogramming" or "reprogrammed" as used herein refers to                                                   
                                 materials and methods that can convert a non-totipotent cell into an totipotent                                       
                                 cell.                                                                                                                 
                         Strelchenko Application 09/357,445, Paper I (specification), p. 12,11. 17-18.                                                 
                F 58. The reprogramming of non-embryonic cells to make them totipotent is said to be a unique                                          
                         feature of Strelchenko's invention:                                                                                           
                                 A unique feature ofthe present invention isthat immortalized, totipotentcells                                         
                                 are reprogrammed from non-embryonic cells by utilizing the materials and                                              
                                 methods described herein in descriptions of the preferred embodiments and                                             
                                 exemplary embodiments.                                                                                                
                         Strelchenko Application 09/357,445, Paper I (specification), p. 17,1. 28 - p. 18,1. 2.                                        
                F 59. Strelchenko further emphasizes the importance of reprogramming in allowing cloning to be                                         
                         carried out from virtually any type of "precursor" cell:                                                                      


                                                                      _10-                                                                             







Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007